A complete application in a minute
Tailored resume and cover letter, ready to send.
BlueRock Therapeutics seeks a Senior Director/Vice President, Program Team Leader to own the asset strategy, development plan, and value creation for a prioritized cell therapy asset. You will align senior experts and drive execution across science, CMC, regulatory, and external stakeholders in a lean, matrixed setting.
The role culminates in leading milestones from IND‑enabling work to first‑in‑human readiness, ensuring rigorous scientific standards and patient safety while shaping portfolio
BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENE™ platform, we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases.
Founded in 2016, BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.
Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies.
We are passionate about realizing the promise of cell and gene therapy, shaping the future of regenerative medicine, and delivering new therapies to patients with limited or no treatment options.
BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELL+GENE™ platform, we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases.
Founded in 2016, BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic, functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.
The Senior Director/Vice President, Program Team Leader is the single point of accountability for the strategy, value creation, and delivery of a priority BlueRock asset. The initial assignment is expected to be our next-generation cell therapy for Parkinson's disease. Asset responsibility will evolve with portfolio priorities.
This leader will align senior functional experts around a clear asset vision, integrated development plan, and decisive path to execution. The role requires an accomplished drug developer who can operate credibly across science, technical operations, development, governance, and external stakeholders in a lean, matrixed environment.
The role reports to the Chief Executive Officer until the program reaches an established transition point in late-stage development.
At BlueRock, we celebrate diversity and are proud to be an equal opportunity workplace. We are committed to providing accommodation for candidates with different abilities or other needs protected by human rights legislation during the recruitment process.
The estimated compensation range for this position is $ 307,000.00 - $ 325,350.00 per year.
Equal Opportunity Workplace: At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.
We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.